Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Ulcerative Colitis Topic Center

Featured Content

News
Upadacitinib vs Tofacitinib for Clinical Remission in Ulcerative Colitis
08/09/2024
Investigators conducted a head-to-head trial of the 2 JAK inhibitors to determine which performed best in achieving steroid-free clinical remission among patients with ulcerative colitis
Investigators conducted a head-to-head trial of the 2 JAK inhibitors to determine which performed best in achieving steroid-free clinical remission among patients with ulcerative colitis
Investigators conducted a...
08/09/2024
Advances in Inflammatory Bowel Disease Network
News
Do Preop Antibiotics Raise the Risk for Pouchitis?
08/07/2024
A recent study examined whether the use of antibiotics prior to ileal pouch-anal anastomosis surgery was associated with the development of acute pouchitis.
A recent study examined whether the use of antibiotics prior to ileal pouch-anal anastomosis surgery was associated with the development of acute pouchitis.
A recent study examined whether...
08/07/2024
Advances in Inflammatory Bowel Disease Network
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
From Gastroenterology
Christina Ha
Conference Coverage
Christina Ha, MD, on Using Comparative Effectiveness Data in Treating Ulcerative Colitis
07/19/2024
“The safest treatment is often the treatment that effectively controls ulcerative colitis," Dr Christina Ha told the audience at the Advances in Inflammatory Bowel Disease regional meeting in Chicago, Illinois, July 19.
“The safest treatment is often the treatment that effectively controls ulcerative colitis," Dr Christina Ha told the audience at the Advances in Inflammatory Bowel Disease regional meeting in Chicago, Illinois, July 19.
“The safest treatment is often...
07/19/2024
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Video
Edward Barnes, MD, on Updates in Ulcerative Colitis
07/17/2024
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on...
07/17/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Risankizumab for Ulcerative Colitis
06/20/2024
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
The approval makes risankizumab...
06/20/2024
Advances in Inflammatory Bowel Disease Network
Laura Raffals
Video
Laura Raffals, MD, on Top Pearls for Managing Ulcerative Colitis
06/13/2024
Dr Raffals reviews her top pearls for ensuring patients with ulcerative colitis are correctly diagnosed, properly treated and monitored, and benefit from multidisciplinary care.
Dr Raffals reviews her top pearls for ensuring patients with ulcerative colitis are correctly diagnosed, properly treated and monitored, and benefit from multidisciplinary care.
Dr Raffals reviews her top...
06/13/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
David Rubin, MD, on the QUASAR Maintenance Study of Guselkumab
06/10/2024
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results...
06/10/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference Coverage
Millie Long, MD, on Acute Severe Ulcerative Colitis
06/06/2024
Dr Long discusses the management of acute severe ulcerative colitis, including initiating therapy, when and how to assess response, options for rescue treatment, and the role of the surgeon in determining the best course of care.
Dr Long discusses the management of acute severe ulcerative colitis, including initiating therapy, when and how to assess response, options for rescue treatment, and the role of the surgeon in determining the best course of care.
Dr Long discusses the management...
06/06/2024
Advances in Inflammatory Bowel Disease Network
Uma Mahadevan, MD
Conference Coverage
Maternal or Paternal Exposure in The Tofacitinib Ulcerative Colitis Clinical Program
05/20/2024

Jessica Garlewicz, Digital Managing Editor

Jessica Garlewicz, Digital Managing E...
Further research is warranted to fully understand the safety profile of tofacitinib during pregnancy, but to date outcomes have been positive.
Further research is warranted to fully understand the safety profile of tofacitinib during pregnancy, but to date outcomes have been positive.
Further research is warranted to...
05/20/2024
Advances in Inflammatory Bowel Disease Network

News

News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Bowel Urgency Reflected in Patient Perceptions of UC Severity
02/20/2024
How patients perceive the severity of their ulcerative colitis is affected by the frequency of bowel urgency episodes and accidents, researchers reported at the American College of Gastroenterology Postgraduate Course.
How patients perceive the severity of their ulcerative colitis is affected by the frequency of bowel urgency episodes and accidents, researchers reported at the American College of Gastroenterology Postgraduate Course.
How patients perceive the...
02/20/2024
Advances in Inflammatory Bowel Disease Network
Conference Coverage
ELEVATE UC Trials Demonstrate Response to Treatment with Etrasimod
01/08/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Rectal bleeding and stool frequency are key determinants among patients with ulcerative colitis and can help guide therapy decisions.
Rectal bleeding and stool frequency are key determinants among patients with ulcerative colitis and can help guide therapy decisions.
Rectal bleeding and stool...
01/08/2024
Advances in Inflammatory Bowel Disease Network
News
FDA Approves Interchangeable Biosimilar for Ustekinumab
11/02/2023
The biosimilar was also approved to treat moderate to severe plaque psoriasis and active psoriatic arthritis.
The biosimilar was also approved to treat moderate to severe plaque psoriasis and active psoriatic arthritis.
The biosimilar was also approved...
11/02/2023
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Mirikizumab for Adults With Moderately to Severely Active Ulcerative Colitis
10/27/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
The LUCENT trial demonstrated the safety and efficacy of the interleukin-23/p19 subunit inhibitor.
The LUCENT trial demonstrated the safety and efficacy of the interleukin-23/p19 subunit inhibitor.
The LUCENT trial demonstrated...
10/27/2023
Advances in Inflammatory Bowel Disease Network
News
FDA Approves New Oral Treatment for Ulcerative Colitis
10/13/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
The U.S. Food and Drug Administration approved etrasimod for the treatment of moderate to severe ulcerative colitis among adults.
The U.S. Food and Drug Administration approved etrasimod for the treatment of moderate to severe ulcerative colitis among adults.
The U.S. Food and Drug...
10/13/2023
Advances in Inflammatory Bowel Disease Network
FDA alert
News
FDA Approves Subcutaneous Vedolizumab for Maintenance of UC
09/28/2023
Single-dose pens should be available by late October, Takeda announced.
Single-dose pens should be available by late October, Takeda announced.
Single-dose pens should be...
09/28/2023
Advances in Inflammatory Bowel Disease Network
News
Ileoanal Pouch And Its Association With Incidental Colorectal Dysplasia
01/22/2023
Researchers sought to ascertain the long-term outcomes of an ileoanal pouch in the event of diagnosis of dysplasia during colonoscopy.
Researchers sought to ascertain the long-term outcomes of an ileoanal pouch in the event of diagnosis of dysplasia during colonoscopy.
Researchers sought to ascertain...
01/22/2023
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistance in CD Patients With Prior Biologic Use
08/26/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
08/26/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/12/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
News
Study Finds Higher-Than-Expected IBD Rates in US Black Women
05/02/2024

Jolynn Tumolo

Jolynn Tumolo
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory...
05/02/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Subcutaneous Vedolizumab for Maintenance Therapy in Crohn’s Disease
04/22/2024
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug...
04/22/2024
Advances in Inflammatory Bowel Disease Network
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Post-Menopausal Women With IBD and Hormone Replacement Therapy
04/05/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to...
04/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network

Insights

Ed Barnes
Video
Edward Barnes, MD, on Updates in Ulcerative Colitis
07/17/2024
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on...
07/17/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
Laura Raffals
Video
Laura Raffals, MD, on Top Pearls for Managing Ulcerative Colitis
06/13/2024
Dr Raffals reviews her top pearls for ensuring patients with ulcerative colitis are correctly diagnosed, properly treated and monitored, and benefit from multidisciplinary care.
Dr Raffals reviews her top pearls for ensuring patients with ulcerative colitis are correctly diagnosed, properly treated and monitored, and benefit from multidisciplinary care.
Dr Raffals reviews her top...
06/13/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
David Rubin, MD, on the QUASAR Maintenance Study of Guselkumab
06/10/2024
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results...
06/10/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference Coverage
Millie Long, MD, on Acute Severe Ulcerative Colitis
06/06/2024
Dr Long discusses the management of acute severe ulcerative colitis, including initiating therapy, when and how to assess response, options for rescue treatment, and the role of the surgeon in determining the best course of care.
Dr Long discusses the management of acute severe ulcerative colitis, including initiating therapy, when and how to assess response, options for rescue treatment, and the role of the surgeon in determining the best course of care.
Dr Long discusses the management...
06/06/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
How I Treat Ulcerative Colitis: David Rubin, MD
04/30/2024
Dr Rubin provides an in-depth look at the treatment of ulcerative colitis, from setting patient expectations to positioning therapies and monitoring for disease remission or progression.
Dr Rubin provides an in-depth look at the treatment of ulcerative colitis, from setting patient expectations to positioning therapies and monitoring for disease remission or progression.
Dr Rubin provides an in-depth...
04/30/2024
Advances in Inflammatory Bowel Disease Network
Ray
Video
Raymond Cross, MD, on JAK Inhibitors in IBD
04/27/2024
Dr Cross reviews his presentation from the AIBD regional meeting on the use, safety, and positioning of Janus kinase inhibitors for the treatment of IBD.
Dr Cross reviews his presentation from the AIBD regional meeting on the use, safety, and positioning of Janus kinase inhibitors for the treatment of IBD.
Dr Cross reviews his...
04/27/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
David Rubin, MD, on Evolving Goals in the Management of Ulcerative Colitis
03/13/2024
Dr Rubin discusses the evolution of treatment goals with ulcerative colitis, including discussing with patients quality of life issues, urgency, functionality, and the potential for remission.
Dr Rubin discusses the evolution of treatment goals with ulcerative colitis, including discussing with patients quality of life issues, urgency, functionality, and the potential for remission.
Dr Rubin discusses the evolution...
03/13/2024
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Conference Coverage
Edward Loftus, MD, on Risankizumab as Induction Therapy for Ulcerative Colitis
11/08/2023
Dr Loftus, from Mayo Clinic in Rochester, Minnesota, reviews results from the phase 3 INSPIRE trial of risankizumab for induction of remission among patients with moderate to severe ulcerative colitis.
Dr Loftus, from Mayo Clinic in Rochester, Minnesota, reviews results from the phase 3 INSPIRE trial of risankizumab for induction of remission among patients with moderate to severe ulcerative colitis.
Dr Loftus, from Mayo Clinic in...
11/08/2023
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal, MD, on Inflammatory and Functional Pouch Disorders
06/07/2023
Dr Kayal, from the Icahn School of Medicine at Mt Sinai, discusses her presentation from Digestive Disease Week on complications of the pouch among patients who have undergone ileal pouch anal anastamosis.
Dr Kayal, from the Icahn School of Medicine at Mt Sinai, discusses her presentation from Digestive Disease Week on complications of the pouch among patients who have undergone ileal pouch anal anastamosis.
Dr Kayal, from the Icahn School...
06/07/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti
Video
Jessica Allegretti, MD, on Recent Advances in Anti-Interleukin Therapies
07/19/2024
Dr Allegretti provides key take-home points from her presentation at the AIBD regional meeting on how anti-interleukin therapies work to treat both Crohn's disease and ulcerative colitis,
Dr Allegretti provides key take-home points from her presentation at the AIBD regional meeting on how anti-interleukin therapies work to treat both Crohn's disease and ulcerative colitis,
Dr Allegretti provides key...
07/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Video
Edward Barnes, MD, on Updates in Ulcerative Colitis
07/17/2024
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on...
07/17/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Positioning Advanced Therapies for IBD
07/02/2024
Dr Rubin recaps his address at Digestive Disease Week on positioning advanced therapies in IBD, emphasizing the importance of assessing disease activity, prognosis for complications, and using a treat to target approach to achieve and...
Dr Rubin recaps his address at Digestive Disease Week on positioning advanced therapies in IBD, emphasizing the importance of assessing disease activity, prognosis for complications, and using a treat to target approach to achieve and...
Dr Rubin recaps his address at...
07/02/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
Laura Raffals
Video
Laura Raffals, MD, on Top Pearls for Managing Ulcerative Colitis
06/13/2024
Dr Raffals reviews her top pearls for ensuring patients with ulcerative colitis are correctly diagnosed, properly treated and monitored, and benefit from multidisciplinary care.
Dr Raffals reviews her top pearls for ensuring patients with ulcerative colitis are correctly diagnosed, properly treated and monitored, and benefit from multidisciplinary care.
Dr Raffals reviews her top...
06/13/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of ECCO With Dr Frank Farraye
06/12/2024
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of...
06/12/2024
Advances in Inflammatory Bowel Disease Network

Interactive Features

medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
OR shot
Quiz
Colectomy Rates Among Patients With UC
02/22/2023
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates...
02/22/2023
Advances in Inflammatory Bowel Disease Network
quiz
Quiz
Does Crohn's Disease or Ulcerative Colitis Present the Highest Risk of Multiple EIMs?
12/11/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Extraintestinal manifestations (EIMs) are seen in 25-40% of patients with inflammatory bowel disease. Take a quick quiz to find out who is more at risk of developing multiple EIMs.
Extraintestinal manifestations (EIMs) are seen in 25-40% of patients with inflammatory bowel disease. Take a quick quiz to find out who is more at risk of developing multiple EIMs.
Extraintestinal manifestations...
12/11/2023
Advances in Inflammatory Bowel Disease Network
light bulb+quiz
Quiz
Positioning Diet for Crohn's Disease
09/04/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
David Rubin, MD, explained some key differences between the different diets in the management of Crohn's disease to achieve the best possible outcomes. Do you know what diet is the most palatable and sustainable? Take our quiz to find out!
David Rubin, MD, explained some key differences between the different diets in the management of Crohn's disease to achieve the best possible outcomes. Do you know what diet is the most palatable and sustainable? Take our quiz to find out!
David Rubin, MD, explained some...
09/04/2023
Advances in Inflammatory Bowel Disease Network
quiz
Quiz
The 3 Pillars of IBD Care
07/18/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Do you know the essential principles of management of inflammatory bowel disease? Take a quick quiz to find out!
Do you know the essential principles of management of inflammatory bowel disease? Take a quick quiz to find out!
Do you know the essential...
07/18/2023
Advances in Inflammatory Bowel Disease Network
medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
Quiz
Role of Biologic Agents in IBD
06/14/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Are biologic agents the ultimate answer in the treatment of intestinal inflammation? Test your knowledge here!
Are biologic agents the ultimate answer in the treatment of intestinal inflammation? Test your knowledge here!
Are biologic agents the ultimate...
06/14/2023
Advances in Inflammatory Bowel Disease Network
coffee+quiz
Quiz
Resection or Medical Therapy for Early Ileocecal Crohn Disease?
05/24/2023
Experts explored the possibility of resection for patients with Crohn disease in the early stages. What did they conclude? Take our quiz to test your knowledge!
Experts explored the possibility of resection for patients with Crohn disease in the early stages. What did they conclude? Take our quiz to test your knowledge!
Experts explored the possibility...
05/24/2023
Advances in Inflammatory Bowel Disease Network
doc writing notes
Quiz
SIBO and Crohn's Disease
04/28/2023
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small...
04/28/2023
Advances in Inflammatory Bowel Disease Network
Clostridioides difficile
Quiz
Increased Risk of Clostridioides difficile Among Patients with IBD
04/01/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
In her presentation at the virtual Advances in Inflammatory Bowel Disease meeting on April 30, Monika Fischer, MD, stated, “Individuals with IBD [inflammatory bowel disease] are at 5-fold risk of getting CDI [Clostridioides difficile], more...
In her presentation at the virtual Advances in Inflammatory Bowel Disease meeting on April 30, Monika Fischer, MD, stated, “Individuals with IBD [inflammatory bowel disease] are at 5-fold risk of getting CDI [Clostridioides difficile], more...
In her presentation at the...
04/01/2023
Advances in Inflammatory Bowel Disease Network
OR shot
Quiz
Colectomy Rates Among Patients With UC
02/22/2023
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates...
02/22/2023
Advances in Inflammatory Bowel Disease Network
colonoscopy
Quiz
Endoscopic Healing in Crohn Disease
07/04/2022
A recent study compared the rates of endoscopic healing after 1 year of therapy with different classes of medications. Do you know which won out? Take our quiz to find out!
A recent study compared the rates of endoscopic healing after 1 year of therapy with different classes of medications. Do you know which won out? Take our quiz to find out!
A recent study compared the...
07/04/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest News

News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Bowel Urgency Reflected in Patient Perceptions of UC Severity
02/20/2024
How patients perceive the severity of their ulcerative colitis is affected by the frequency of bowel urgency episodes and accidents, researchers reported at the American College of Gastroenterology Postgraduate Course.
How patients perceive the severity of their ulcerative colitis is affected by the frequency of bowel urgency episodes and accidents, researchers reported at the American College of Gastroenterology Postgraduate Course.
How patients perceive the...
02/20/2024
Advances in Inflammatory Bowel Disease Network
Conference Coverage
ELEVATE UC Trials Demonstrate Response to Treatment with Etrasimod
01/08/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Rectal bleeding and stool frequency are key determinants among patients with ulcerative colitis and can help guide therapy decisions.
Rectal bleeding and stool frequency are key determinants among patients with ulcerative colitis and can help guide therapy decisions.
Rectal bleeding and stool...
01/08/2024
Advances in Inflammatory Bowel Disease Network
News
FDA Approves Interchangeable Biosimilar for Ustekinumab
11/02/2023
The biosimilar was also approved to treat moderate to severe plaque psoriasis and active psoriatic arthritis.
The biosimilar was also approved to treat moderate to severe plaque psoriasis and active psoriatic arthritis.
The biosimilar was also approved...
11/02/2023
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Mirikizumab for Adults With Moderately to Severely Active Ulcerative Colitis
10/27/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
The LUCENT trial demonstrated the safety and efficacy of the interleukin-23/p19 subunit inhibitor.
The LUCENT trial demonstrated the safety and efficacy of the interleukin-23/p19 subunit inhibitor.
The LUCENT trial demonstrated...
10/27/2023
Advances in Inflammatory Bowel Disease Network
News
FDA Approves New Oral Treatment for Ulcerative Colitis
10/13/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
The U.S. Food and Drug Administration approved etrasimod for the treatment of moderate to severe ulcerative colitis among adults.
The U.S. Food and Drug Administration approved etrasimod for the treatment of moderate to severe ulcerative colitis among adults.
The U.S. Food and Drug...
10/13/2023
Advances in Inflammatory Bowel Disease Network
FDA alert
News
FDA Approves Subcutaneous Vedolizumab for Maintenance of UC
09/28/2023
Single-dose pens should be available by late October, Takeda announced.
Single-dose pens should be available by late October, Takeda announced.
Single-dose pens should be...
09/28/2023
Advances in Inflammatory Bowel Disease Network
News
Ileoanal Pouch And Its Association With Incidental Colorectal Dysplasia
01/22/2023
Researchers sought to ascertain the long-term outcomes of an ileoanal pouch in the event of diagnosis of dysplasia during colonoscopy.
Researchers sought to ascertain the long-term outcomes of an ileoanal pouch in the event of diagnosis of dysplasia during colonoscopy.
Researchers sought to ascertain...
01/22/2023
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistance in CD Patients With Prior Biologic Use
08/26/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
08/26/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/12/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
News
Study Finds Higher-Than-Expected IBD Rates in US Black Women
05/02/2024

Jolynn Tumolo

Jolynn Tumolo
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory...
05/02/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Subcutaneous Vedolizumab for Maintenance Therapy in Crohn’s Disease
04/22/2024
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug...
04/22/2024
Advances in Inflammatory Bowel Disease Network
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Post-Menopausal Women With IBD and Hormone Replacement Therapy
04/05/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to...
04/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
David Hudesman
Podcast
David Hudesman, MD, on Efficacy of Tofacitinib Induction for Ulcerative Colitis
03/07/2023
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings...
03/07/2023
Advances in Inflammatory Bowel Disease Network
Bruce Sands
Podcast
Bruce Sands, MD, on the VEGA Study of Combination Biologic Therapy in UC
12/19/2022
Dr Sands provides an overview of the VEGA study, the first of its kind to combine 2 biologic agents to attempt to achieve higher rates of remission among patients with ulcerative colitis.
Dr Sands provides an overview of the VEGA study, the first of its kind to combine 2 biologic agents to attempt to achieve higher rates of remission among patients with ulcerative colitis.
Dr Sands provides an overview of...
12/19/2022
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of ECCO With Dr Frank Farraye
06/12/2024
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of...
06/12/2024
Advances in Inflammatory Bowel Disease Network
Rishika Chugh
Podcast
Rishika Chugh, MD: Safety of Vedolizumab and Ustekinumab in Pregnancy
05/28/2024
Dr Chugh reviews the results of a recent study of the safety of ustekinumab and vedolizumab among pregnant patients with inflammatory bowel disease.
Dr Chugh reviews the results of a recent study of the safety of ustekinumab and vedolizumab among pregnant patients with inflammatory bowel disease.
Dr Chugh reviews the results of...
05/28/2024
Advances in Inflammatory Bowel Disease Network
Noa Cleveland
Podcast
Noa Krugliak Cleveland, MD, on Intestinal Ultrasound in Clinical Practice
05/22/2024
Dr Krugliak Cleveland reviews the results of research and real-world experience in using intestinal ultrasound in clinical practice when diagnosing and monitoring inflammatory bowel disease.
Dr Krugliak Cleveland reviews the results of research and real-world experience in using intestinal ultrasound in clinical practice when diagnosing and monitoring inflammatory bowel disease.
Dr Krugliak Cleveland reviews...
05/22/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Gary Lichtenstein, MD, on the Best of ECCO
05/06/2024
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its...
05/06/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Siddharth Singh: AGA Guidelines on Using Biomarkers in Ulcerative Colitis
04/25/2024
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive...
04/25/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement